These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24363547)

  • 1. The effect of cotrimoxazole prophylactic treatment on malaria, birth outcomes, and postpartum CD4 count in HIV-infected women.
    Dow A; Kayira D; Hudgens MG; Van Rie A; King CC; Ellington S; Chome N; Kourtis A; Turner AN; Kacheche Z; Jamieson DJ; Chasela C; van der Horst C
    Infect Dis Obstet Gynecol; 2013; 2013():340702. PubMed ID: 24363547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.
    Walter J; Mwiya M; Scott N; Kasonde P; Sinkala M; Kankasa C; Kauchali S; Aldrovandi GM; Thea DM; Kuhn L
    J Infect Dis; 2006 Dec; 194(11):1510-8. PubMed ID: 17083035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa.
    Choi SE; Brandeau ML; Bendavid E
    Malar J; 2017 Oct; 16(1):403. PubMed ID: 28985732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial.
    González R; Desai M; Macete E; Ouma P; Kakolwa MA; Abdulla S; Aponte JJ; Bulo H; Kabanywanyi AM; Katana A; Maculuve S; Mayor A; Nhacolo A; Otieno K; Pahlavan G; Rupérez M; Sevene E; Slutsker L; Vala A; Williamsom J; Menéndez C
    PLoS Med; 2014 Sep; 11(9):e1001735. PubMed ID: 25247995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
    Hamer DH; Mwanakasale V; Macleod WB; Chalwe V; Mukwamataba D; Champo D; Mwananyanda L; Chilengi R; Mubikayi L; Mulele CK; Mulenga M; Thea DM; Gill CJ
    J Infect Dis; 2007 Dec; 196(11):1585-94. PubMed ID: 18008241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.
    Denoeud-Ndam L; Zannou DM; Fourcade C; Taron-Brocard C; Porcher R; Atadokpede F; Komongui DG; Dossou-Gbete L; Afangnihoun A; Ndam NT; Girard PM; Cot M
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):198-206. PubMed ID: 24220287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis.
    Mbeye NM; ter Kuile FO; Davies MA; Phiri KS; Egger M; Wandeler G;
    Trop Med Int Health; 2014 Sep; 19(9):1057-67. PubMed ID: 25039469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi.
    Gutman J; Mwandama D; Wiegand RE; Ali D; Mathanga DP; Skarbinski J
    J Infect Dis; 2013 Sep; 208(6):907-16. PubMed ID: 23801600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of daily cotrimoxazole on clinical malaria and asymptomatic parasitemias in HIV-exposed, uninfected infants.
    Davis NL; Barnett EJ; Miller WC; Dow A; Chasela CS; Hudgens MG; Kayira D; Tegha G; Ellington SR; Kourtis AP; van der Horst C; Jamieson DJ; Juliano JJ
    Clin Infect Dis; 2015 Aug; 61(3):368-74. PubMed ID: 25900173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cotrimoxazole prophylactic treatment on adverse health outcomes among HIV-exposed, uninfected infants.
    Dow A; Kayira D; Hudgens M; Van Rie A; King CC; Ellington S; Kourtis A; Turner AN; Meshnick S; Kacheche Z; Jamieson DJ; Chasela C; van der Horst C
    Pediatr Infect Dis J; 2012 Aug; 31(8):842-7. PubMed ID: 22801093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
    Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
    J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-trimoxazole Prophylaxis, Asymptomatic Malaria Parasitemia, and Infectious Morbidity in Human Immunodeficiency Virus-Exposed, Uninfected Infants in Malawi: The BAN Study.
    Davis NL; Wiener J; Juliano JJ; Adair L; Chasela CS; Kayira D; Hudgens MG; van der Horst C; Jamieson DJ; Kourtis AP; ;
    Clin Infect Dis; 2017 Aug; 65(4):575-580. PubMed ID: 28444232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Effect of Indoor Residual Spraying of Insecticide on Preterm Birth Among Pregnant Women With HIV Infection in Uganda: A Secondary Data Analysis.
    Roh ME; Shiboski S; Natureeba P; Kakuru A; Muhindo M; Ochieng T; Plenty A; Koss CA; Clark TD; Awori P; Nakalambe M; Cohan D; Jagannathan P; Gosling R; Havlir DV; Kamya MR; Dorsey G
    J Infect Dis; 2017 Dec; 216(12):1541-1549. PubMed ID: 29029337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.
    Gill CJ; Macleod WB; Mwanakasale V; Chalwe V; Mwananyanda L; Champo D; Mukwamataba D; Chilengi R; Thea DM; Hamer DH
    J Infect Dis; 2007 Dec; 196(11):1577-84. PubMed ID: 18008240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial.
    Diakite OS; Kayentao K; Traoré BT; Djimde A; Traoré B; Diallo M; Ongoiba A; Doumtabé D; Doumbo S; Traoré MS; Dara A; Guindo O; Karim DM; Coulibaly S; Bougoudogo F; Ter Kuile FO; Danis M; Doumbo OK
    Clin Infect Dis; 2011 Aug; 53(3):215-23. PubMed ID: 21765069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights Into Circulating Cytokine Dynamics During Pregnancy in HIV-Infected Beninese Exposed to Plasmodium falciparum Malaria.
    Ibitokou SA; Denoeud-Ndam L; Ezinmegnon S; Ladékpo R; Zannou DM; Massougbodji A; Girard PM; Cot M; Luty AJ; Ndam NT
    Am J Trop Med Hyg; 2015 Aug; 93(2):287-92. PubMed ID: 26101276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa.
    Hoffmann CJ; Fielding KL; Charalambous S; Innes C; Chaisson RE; Grant AD; Churchyard GJ
    AIDS; 2010 Jul; 24(11):1709-16. PubMed ID: 20495439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya.
    Green M; Otieno K; Katana A; Slutsker L; Kariuki S; Ouma P; González R; Menendez C; ter Kuile F; Desai M
    Malar J; 2016 Jan; 15():7. PubMed ID: 26732683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
    Capan-Melser M; Mombo Ngoma G; Akerey-Diop D; Basra A; Würbel H; Groger M; Mackanga JR; Zoleko-Manego R; Schipulle U; Schwing J; Lötsch F; Rehman K; Matsiegui PB; Agnandji ST; Adegnika AA; Bélard S; González R; Kremsner PG; Menendez C; Ramharter M
    J Antimicrob Chemother; 2015; 70(6):1898-902. PubMed ID: 25722300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.